2019
DOI: 10.1016/j.isci.2018.12.037
|View full text |Cite
|
Sign up to set email alerts
|

TRAIL-Expressing Monocyte/Macrophages Are Critical for Reducing Inflammation and Atherosclerosis

Abstract: SummaryCirculating tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) levels are reduced in patients with cardiovascular disease, and TRAIL gene deletion in mice exacerbates atherosclerosis and inflammation. How TRAIL protects against atherosclerosis and why levels are reduced in disease is unknown. Here, multiple strategies were used to identify the protective source of TRAIL and its mechanism(s) of action. Samples from patients with coronary artery disease and bone-marrow transplantation e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
49
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 41 publications
(50 citation statements)
references
References 47 publications
1
49
0
Order By: Relevance
“…Interestingly, genetic deletion of the receptor for TNF‐related apoptosis‐inducing ligand (TRAIL) exacerbates the ductular reaction and causes parenchymal, bridging fibrosis in the Mdr2 −/− mouse ( Mdr2 −/− Tr −/− ), suggesting that TRAIL proapoptotic signaling may restrain the expansion of DRCs, which, in turn, can influence HSC activation. Indeed, these mice exhibit expansion of a subpopulation of restorative macrophages (Mer protooncogene tyrosine kinase + /cluster of differentiation 206 + /galectin 2 + ) expressing TRAIL, pointing to an ongoing compensatory process to restrain the number of DRCs …”
Section: The Proliferative Cholangiocyte Compartment In Psc: Drcsmentioning
confidence: 99%
See 1 more Smart Citation
“…Interestingly, genetic deletion of the receptor for TNF‐related apoptosis‐inducing ligand (TRAIL) exacerbates the ductular reaction and causes parenchymal, bridging fibrosis in the Mdr2 −/− mouse ( Mdr2 −/− Tr −/− ), suggesting that TRAIL proapoptotic signaling may restrain the expansion of DRCs, which, in turn, can influence HSC activation. Indeed, these mice exhibit expansion of a subpopulation of restorative macrophages (Mer protooncogene tyrosine kinase + /cluster of differentiation 206 + /galectin 2 + ) expressing TRAIL, pointing to an ongoing compensatory process to restrain the number of DRCs …”
Section: The Proliferative Cholangiocyte Compartment In Psc: Drcsmentioning
confidence: 99%
“…Indeed, these mice exhibit expansion of a subpopulation of restorative macrophages (Mer protooncogene tyrosine kinase + /cluster of differentiation 206 + /galectin 2 + ) expressing TRAIL, pointing to an ongoing compensatory process to restrain the number of DRCs. (30)(31)(32)…”
Section: The Proliferative Cholangiocyte Compartment In Psc: Drcsmentioning
confidence: 99%
“…Indeed, recombinant TRAIL administration to diabetic Apoe −/− mice increased VSMC-positive cell numbers within the plaque cap with a tendency for increased collagen ( 76 ). These are significant since plasma TRAIL levels are suppressed in patients with atherosclerosis ( 77 , 78 , 79 , 80 ).…”
Section: Trail Signals and Vascular Remodellingmentioning
confidence: 99%
“…11 cDNA was synthesized as described. 11,12 Real-time qPCR was performed, and relative expression was determined using the 2 −∆∆Ct method using rat primers described in Table 1, normalized to GAPDH or β-actin house-keeping genes.…”
Section: Quantitative Pcr (Qpcr)mentioning
confidence: 99%
“…15 2-8 wk, n = 4-6). Body weights (C) at the beginning of the study (n = [11][12] and (D) after 8-wk feeding (n = 5-6), and (E) weight gain over the course of the study (n = 5-6). Results are mean ± SEM two-way ANOVA, t test or one-way ANOVA; *P < .05, **P < .01, ***P < .001, ****P < .0001…”
Section: Shr Rats Have Altered Plasma Chemistriesmentioning
confidence: 99%